Placebo for MMV371

DRUG2 trials

Sponsors

Medicines for Malaria Venture

Conditions

MalariaMalaria (Plasmodium Falciparum)Malaria FalciparumMalaria InfectionMalaria ParasitaemiaMalaria PreventionMalaria ProphylaxisMalaria,Falciparum

Phase 1

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

CompletedNCT06558643

Medicines for Malaria VentureMalaria,Falciparum

Start: 2024-08-27End: 2025-09-03Updated: 2026-05-05

Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda

Not yet recruitingNCT07548021

Medicines for Malaria VentureMalaria, Malaria Falciparum, Malaria Infection +4

Start: 2026-09-01End: 2028-03-01Target: 80Updated: 2026-04-23